Ordinary Adjustment | Solactive China Biotech Index | July 2021
In the ordinary rebalance the following composition will be implemented effective open 12.07.2021:
| JIANGSU HENGRUI MEDICINE CO LTD CLASS A |
| WUXI APPTEC CO LTD-A |
| WUXI BIOLOGICS CAYMAN INC |
| BEIGENE LTD-ADR |
| HANSOH PHARMACEUTICAL GROUP CO |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO LTD |
| CANSINO BIOLOGICS INC |
| SINO BIOPHARMACEUTICAL LTD ORD |
| SHENZHEN KANGTAI BIOLOGICA-A |
| INNOVENT BIOLOGICS INC |
| ZAI LAB LTD |
| WALVAX BIOTECHNOLOGY CO-A |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD |
| HUALAN BIOLOGICAL ENGINEER-A |
| BGI GENOMICS CO LTD-A |
| GENSCRIPT BIOTECH CORP |
| SHANGHAI RAAS BLOOD PRODUC-A |
| BETTA PHARMACEUTICALS CO L-A |
| REMEGEN CO LTD-H |
| BEIJING TIANTAN BIOLOGICAL-A |
| Hygeia Healthcare Holdings Co Ltd |
| CHINA MEDICAL SYSTEM HOLDINGS LTD |
| LIVZON PHARMACEUTICAL GROU-A |
| NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO LTD |
| ZHEJIANG WOLWO BIO-PHARMAC-A |
| DAAN GENE CO LTD-A |
| PHARMABLOCK SCIENCES NANJI-A |
| HUTCHISON CHINA MEDITECH-ADR |
| ANHUI ANKE BIOTECHNOLOGY G-A |
| CHINA NATIONAL MEDICINES-A |